Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL713P (RNA, 7SL, cytoplasmic 713, pseudogene) is a pseudogene that closely resembles the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein involved in targeting secretory proteins to the endoplasmic reticulum[1][3][5][4]. As a pseudogene, RN7SL713P is a non-functional copy of the original gene and does not code for a functional RNA or protein product[1][4]. Pseudogenes like RN7SL713P arise commonly through gene duplication or retrotransposition of RNA, but lack the necessary regulatory elements or contain disabling mutations that prevent them from being functional[4][3]. While the canonical 7SL RNA has regulatory and structural roles in protein targeting and has been implicated in some cancer-related processes, pseudogenes such as RN7SL713P typically do **not** contribute directly to biological function, are not considered therapeutic targets, and have no known role in disease or interaction with drugs[1][4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 713, pseudogene (RN7SL713P).